Effect of Novel Allosteric Modulators of Metabotropic Glutamate Receptors on Drug Self-administration and Relapse: A Review of Preclinical Studies and Their Clinical Implications
Open accessAbstract
Results from preclinical rodent studies during the last 20 years implicated glutamate neurotransmission in different brain regions in drug self-administration and rodent models of relapse. These results, along with evidence for drug-induced neuroadaptations in glutamatergic neurons and receptors, suggested that addiction might be treatable by medications that inhibit glutamatergic responses to drugs of abuse, drug-associated cues, and stressors. This idea is supported by findings in rodent and primate models that drug self-administration and relapse are reduced by systemic injections of antagonists of ionotropic glutamate receptors or metabotropic glutamate receptors (mGluRs) or orthosteric agonists of mGluR2/3. However, these compounds have not advanced to clinical use because of potential side effects and other factors. This state of affairs has led to the development of positive allosteric modulators (PAMs) and negative allosteric modulators (NAMs) of mGluRs. PAMs and NAMs of mGluRs, either of which can inhibit evoked glutamate release, may be suitable for testing in humans. We reviewed results from recent studies of systemically injected PAMs and NAMs of mGluRs in rodents and monkeys, focusing on whether they reduce drug self-administration, reinstatement of drug seeking, and incubation of drug craving. We also review results from rat studies in which PAMs or NAMs of mGluRs were injected intracranially to reduce drug self-administration and reinstatement. We conclude that PAMs and NAMs of mGluRs should be considered for clinical trials.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several studies established a causal role for reduced prefrontal metabotropic glutamate receptor 2 function in craving and relapse responses in preclinical models of alcohol dependence.
“Several studies established a causal role for reduced prefrontal metabotropic glutamate receptor 2 (mGluR2) function in craving and relapse responses in preclinical models of alcohol dependence [48–52].”
From Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial (2024) · cites this paper as [50]
The Group II metabotropic glutamate receptors > Reinstatement section (page unavailable) reports that an mGluR2 modulator reduced cue-induced alcohol seeking in rats, but not in rats lacking functional mGluR2, supporting a causal role for mGluR2 in that relapse response. It does not establish that reduced *prefrontal* mGluR2 function causes craving and relapse in models of alcohol dependence; its alcohol finding concerns cue-induced reinstatement, not craving broadly. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229 · see citing works
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,083 · see citing works
Context, ambiguity, and unlearning: sources of relapse after behavioral extinction
Bouton, M. E. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01546-9 · Cited by 1,662 · see citing works
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615 · see citing works
Self-citationThe glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · see citing works
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,337 · see citing works
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239 · see citing works
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons
Ungless, M. A., Whistler, J. L., Malenka, R. C., & Bonci, A. (2001) · Nature · doi:10.1038/35079077 · Cited by 1,106 · see citing works
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063 · see citing works
Pharmacological agents acting at subtypes of metabotropic glutamate receptors
Schoepp, D. D., Jane, D. E., & Monn, J. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00092-1 · Cited by 1,061 · see citing works
The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
Wolf, M. E. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00090-7 · Cited by 934 · see citing works
The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior
McFarland, K., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08655.2001 · Cited by 905 · see citing works
McFarland, K., Lapish, C. C., & Kalivas, P. W. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03531.2003 · Cited by 884 · see citing works
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880 · see citing works
Self-citationMetabotropic glutamate receptors: electrophysiological properties and role in plasticity
Anwyl, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00050-2 · Cited by 776 · see citing works
Nakajima, Y., Iwakabe, H., Akazawa, C., Nawa, H., Shigemoto, R., Mizuno, N., & Nakanishi, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50280-0 · Cited by 739 · see citing works
Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00082-9 · Cited by 725 · see citing works
Long-term potentiation of excitatory inputs to brain reward areas by nicotine
Mansvelder, H. D., & McGehee, D. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00042-8 · Cited by 720 · see citing works
Applying extinction research and theory to cue‐exposure addiction treatments
Conklin, C. A., & Tiffany, S. T. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00014.x · Cited by 702 · see citing works
Methods of Assessing the Reinforcing Properties of Abused Drugs
Bozarth, M. A. (1987) · Springer eBooks · doi:10.1007/978-1-4612-4812-5 · Cited by 693 · see citing works
Schoepp, D. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 693 · see citing works
Neurobiology of the incubation of drug craving
Pickens, C. L., Airavaara, M., Theberge, F. R. M., Fanous, S., Hope, B. T., & Shaham, Y. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.001 · Cited by 634 · see citing works
Self-citationBrain circuitry and the reinstatement of cocaine-seeking behavior
Kalivas, P., & McFarland, K. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1393-2 · Cited by 613 · see citing works
Ohishi, H., Shigemoto, R., Nakanishi, S., & Mizuno, N. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90485-x · Cited by 560 · see citing works
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
Chiamulera, C., Epping-Jordan, M. P., Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S., Corsi, M., Orzi, F., & Conquet, F. (2001) · Nature Neuroscience · doi:10.1038/nn0901-873 · Cited by 554 · see citing works
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 546 · see citing works
Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain
Shigemoto, R., Nomura, S., Ohishi, H., Sugihara, H., Nakanishi, S., & Mizuno, N. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90227-c · Cited by 521 · see citing works
Neuroadaptations involved in amphetamine and cocaine addiction
White, F. J., & Kalivas, P. W. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00072-6 · Cited by 509 · see citing works
Emerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498 · see citing works
Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801
Karler, R., Calder, L. I., Chaudhry, I. A., & Turkanis, S. A. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90045-3 · Cited by 488 · see citing works
Bossert, J. M., Marchant, N. J., Calu, D. J., & Shaham, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3120-y · Cited by 453 · see citing works
Self-citationStress-induced reinstatement of drug seeking: 20 years of progress
Mantsch, J. R., Baker, D. A., Funk, D., Lê, A. D., & Shaham, Y. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.142 · Cited by 438 · see citing works
Self-citationMolecular Neurobiology of Addiction
Nestler, E. J. (2001) · American Journal on Addictions · doi:10.1080/105504901750532094 · Cited by 412 · see citing works
Hermans, E., & Challiss, R. A. J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590465 · Cited by 402 · see citing works
Synaptic mechanisms underlying persistent cocaine craving
Wolf, M. E. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.39 · Cited by 389 · see citing works
Kalivas, P. W., & Alesdatter, J. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39530-3 · Cited by 368 · see citing works
Tamaru, Y., Nomura, S., Mizuno, N., & Shigemoto, R. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00305-0 · Cited by 345 · see citing works
Ciano, P. D., & Everitt, B. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1581-04.2004 · Cited by 333 · see citing works
Park, W.-K., Bari, A., Jey, A. R., Anderson, S. M., Spealman, R. D., Rowlett, J. K., & Pierce, R. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02916.2002 · Cited by 310 · see citing works
Porter, R. H. P., Jaeschke, G., Spooren, W., Ballard, T. M., Büttelmann, B., Kolczewski, S., Peters, J.-U., Prinssen, E., Wichmann, J., Vieira, E., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089839 · Cited by 308 · see citing works
Fuchs, R. A., Branham, R. K., & See, R. E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5146-05.2006 · Cited by 298 · see citing works
Time to connect: bringing social context into addiction neuroscience
Heilig, M., Epstein, D. H., Nader, M. A., & Shaham, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.67 · Cited by 298 · see citing works
Self-citationMonn, J. A., Valli, M. J., Massey, S. M., Hansen, M. M., Kress, T. J., Wepsiec, J. P., Harkness, A. R., John L. Grutsch, Wright, R. A., Johnson, B. G., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980616n · Cited by 293 · see citing works
Ciano, P. D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00235-4 · Cited by 287 · see citing works
Hermans, E., & Challiss, R. A. J. (2001) · Biochemical Journal · doi:10.1042/bj3590465 · Cited by 270 · see citing works
Conn, P. J., Lindsley, C. W., Meiler, J., & Niswender, C. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4308 · Cited by 259 · see citing works
Neural substrates of conditioned-cued relapse to drug-seeking behavior
See, R. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00682-7 · Cited by 257 · see citing works
Cocaine‐induced neuroadaptations in glutamate transmission
Schmidt, H. D., & Pierce, R. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05144.x · Cited by 254 · see citing works
A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior
Cornish, J. L., Duffy, P., & Kalivas, P. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00214-6 · Cited by 249 · see citing works
Corti, C., Aldegheri, L., Somogyi, P., & Ferraguti, F. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00591-7 · Cited by 243 · see citing works
A Role of Ventral Tegmental Area Glutamate in Contextual Cue-Induced Relapse to Heroin Seeking
Bossert, J. M., Liu, S. Y., Lu, L., & Shaham, Y. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3207-04.2004 · Cited by 241 · see citing works
Self-citationMitsukawa, K., Yamamoto, R., Ofner, S., Nozulak, J., Pescott, O. L., Lukić, S., Stoehr, N., Mombereau, C., Kuhn, R. R., McAllister, K. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508063102 · Cited by 240 · see citing works
Wolf, M. E., & Khansa, M. R. (1991) · Brain Research · doi:10.1016/0006-8993(91)91202-c · Cited by 237 · see citing works
Baptista, M. A. S., Martin‐Fardon, R., & Weiss, F. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0176-04.2004 · Cited by 235 · see citing works
Bonci, A., & Williams, J. T. (1996) · Neuron · doi:10.1016/s0896-6273(00)80082-3 · Cited by 228 · see citing works
The ups and downs of addiction: role of metabotropic glutamate receptors
Kenny, P. J., & Markou, A. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.009 · Cited by 223 · see citing works
Rate-dependent effects of drugs: A review of the literature
Sanger, D. J., & Blackman, D. E. (1976) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(76)90178-7 · Cited by 222 · see citing works
Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals
Vendruscolo, L. F., Estey, D., Goodell, V., Macshane, L. G., Logrip, M. L., Schlosburg, J. E., McGinn, M. A., Zamora-Martinez, E. R., Belanoff, J. K., Hunt, H. J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79828 · Cited by 218 · see citing works
Bowers, M. S., Chen, B. T., & Bonci, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.06.004 · Cited by 218 · see citing works
Zhang, X. F., Hu, X.-T., White, F. J., & Wolf, M. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36671-6 · Cited by 210 · see citing works
Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction
Olive, M. F. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010083 · Cited by 201 · see citing works
Liechti, M. E., Lhuillier, L., Kaupmann, K., & Markou, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-07.2007 · Cited by 193 · see citing works
Lü, L., Uejima, J. L., Gray, S. M., Bossert, J. M., & Shaham, Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.011 · Cited by 192 · see citing works
Self-citationModulation of Group II Metabotropic Glutamate Receptor Signaling by Chronic Cocaine
Xi, Z., Ramamoorthy, S., Baker, D. L., Shen, H., Samuvel, D. J., & Kalivas, P. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039735 · Cited by 181 · see citing works
Stewart, J., & Druhan, J. P. (1993) · Psychopharmacology · doi:10.1007/bf02246961 · Cited by 179 · see citing works
Rational Development of Addiction Pharmacotherapies: Successes, Failures, and ProspectsPreprint
Pierce, R. C., O'Brien, C. P., Kenny, P. J., & Vanderschuren, L. J. M. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012880 · Cited by 178 · see citing works
Mathiesen, J. M., Svendsen, N., Bräuner‐Osborne, H., Thomsen, C., & Ramirez, M. T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705159 · Cited by 173 · see citing works
Lindsley, C. W., Wisnoski, D. D., Leister, W., O’Brien, J. A., Lemaire, W., David L. Williams, Burno, M., Sur, C., Kinney, G. G., Pettibone, D. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049400d · Cited by 170 · see citing works
Galici, R., Jones, C. K., Hemstapat, R., Nong, Y., Echemendia, N. G., Williams, L. C., de Paulis, T., & Conn, P. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102046 · Cited by 169 · see citing works
The Central Amygdala Nucleus is Critical for Incubation of Methamphetamine Craving
Li, X., Zeric, T., Kambhampati, S., Bossert, J. M., & Shaham, Y. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.320 · Cited by 163 · see citing works
Self-citationVenniro, M., Caprioli, D., Zhang, M., Whitaker, L. R., Zhang, S., Warren, B. L., Cifani, C., Marchant, N. J., Yizhar, O., Bossert, J. M., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.024 · Cited by 162 · see citing works
Self-citationSchroeder, J. P., Overstreet, D. H., & Hodge, C. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2175-9 · Cited by 161 · see citing works
Kwako, L. E., Spagnolo, P. A., Schwandt, M. L., Thorsell, A., George, D. T., Momenan, R., Rio, D. E., Huestis, M. A., Anizan, S., Concheiro, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.306 · Cited by 160 · see citing works
Schwandt, M. L., Cortes, C. R., Kwako, L. E., George, D. T., Momenan, R., Sinha, R., Grigoriadis, D. E., Pich, E. M., Leggio, L., & Heilig, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.61 · Cited by 159 · see citing works
Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving
Loweth, J. A., Scheyer, A. F., Milovanovic, M., LaCrosse, A. L., Flores-Barrera, E., Werner, C. T., Li, X., Ford, K. A., Le, T., Olive, M. F., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3590 · Cited by 157 · see citing works
Cue exposure and relapse prevention in the treatment of addictive behaviors
Marlatt, G. A. (1990) · Addictive Behaviors · doi:10.1016/0306-4603(90)90048-3 · Cited by 156 · see citing works
Paterson, N. E., & Markou, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2070-9 · Cited by 155 · see citing works
A Double-Blind Placebo-Controlled Trial of N-Acetylcysteine in the Treatment of Cocaine Dependence
Larowe, S., Kalivas, P., Nicholas, J. S., Randall, P., Mardikian, P., & Malcolm, R. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12034.x · Cited by 154 · see citing works
Hodge, C. W., Miles, M. F., Sharko, A. C., Stevenson, R. A., Hillmann, J. R., Lepoutre, V., Besheer, J., & Schroeder, J. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0217-y · Cited by 153 · see citing works
Kinzie, J. M., Saugstad, J. A., Westbrook, G. L., & Segerson, T. P. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00244-d · Cited by 149 · see citing works
Casabona, G., Knöpfel, T., Kühn, R., et al. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01348.x · Cited by 149 · see citing works
Recent developments in animal models of drug relapse
Marchant, N. J., Li, X., & Shaham, Y. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.003 · Cited by 148 · see citing works
Self-citationVènniro, M., Zhang, M. H., Shaham, Y., & Caprioli, D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.287 · Cited by 147 · see citing works
Self-citationCaprioli, D., Venniro, M., Zeric, T., Li, X., Adhikary, S., Madangopal, R., Marchant, N. J., Lucantonio, F., Schoenbaum, G., Bossert, J. M., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.018 · Cited by 145 · see citing works
Self-citationYokel, R. A. (1987) · Springer eBooks · doi:10.1007/978-1-4612-4812-5_1 · Cited by 143 · see citing works
Caprioli, D., Vènniro, M., Zhang, M. H., Bossert, J. M., Warren, B. L., Hope, B. T., & Shaham, Y. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3091-16.2016 · Cited by 143 · see citing works
Self-citationJNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist
Lavreysen, H., Wouters, R., Bischoff, F., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.007 · Cited by 140 · see citing works
Suzuki, G., Tsukamoto, N., Fushiki, H., Kawagishi, A., Nakamura, M., Kurihara, H., Mitsuya, M., Ohkubo, M., & Ohta, H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124701 · Cited by 132 · see citing works
Lominac, K. D., Kapasova, Z., Hannun, R. A., Patterson, C., Middaugh, L. D., & Szumlinski, K. K. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.003 · Cited by 124 · see citing works
Movsesyan, V. A., O’Leary, D. M., Fan, L., Bao, W., Mullins, P. G., Knoblach, S. M., & Faden, A. I. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29660-9 · Cited by 121 · see citing works
Loss of metabotropic glutamate receptor 2 escalates alcohol consumption
Zhou, Z., Karlsson, C., Liang, T., Xiong, W., Kimura, M., Tapocik, J. D., Yuan, Q., Barbier, E., Feng, A. Y., Flanigan, M. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309839110 · Cited by 115 · see citing works
Anderson, J. J., Rao, S. P., Rowe, B. A., Giracello, D. R., Holtz, G., Chapman, D. F., Tehrani, L. R., BRADBURY, M. J., Cosford, N. D. P., & Varney, M. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040618 · Cited by 104 · see citing works
Kowalczyk, W. J., Phillips, K. A., Jobes, M. L., Kennedy, A. P., Ghitza, U. E., Agage, D. A., Schmittner, J. P., Epstein, D. H., & Preston, K. L. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14081014 · Cited by 101 · see citing works
Recent updates on incubation of drug craving: a mini‐review
Li, X., Caprioli, D., & Marchant, N. J. (2014) · Addiction Biology · doi:10.1111/adb.12205 · Cited by 98 · see citing works
Self-citationAMPA Receptor Plasticity in Accumbens Core Contributes to Incubation of Methamphetamine Craving
Scheyer, A. F., Loweth, J. A., Christian, D., Uejima, J. L., Rabei, R., Le, T. Q., Dolubizno, H., Stefanik, M. T., Murray, C. H., Sakas, C., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.003 · Cited by 98 · see citing works
Regulation of Motivation to Self‐Administer Ethanol by mGluR5 in Alcohol‐Preferring (P) Rats
Besheer, J., Faccidomo, S., Grondin, J. J. M., & Hodge, C. W. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00570.x · Cited by 97 · see citing works
Драволина, О. А., Захарова, Е. С., Шекунова, Е. В., Zvartau, E. E., Danysz, W., & Bespalov, A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.023 · Cited by 93 · see citing works
Neurochemical and operant behavioral studies of a strain of alcohol-preferring rats
Penn, P. E., McBride, W. J., Lumeng, L., Gaff, T. M., & Li, T. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90087-4 · Cited by 89 · see citing works
Adewale, A. S., Platt, D. M., & Spealman, R. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105387 · Cited by 89 · see citing works
Rodd, Z. A., McKinzie, D. L., Bell, R. L., McQueen, V. K., MURPHY, J., Schoepp, D. D., & McBride, W. J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.032 · Cited by 86 · see citing works
Xie, X., Ramirez, D. R., Lasseter, H. C., & Fuchs, R. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1700-7 · Cited by 85 · see citing works
Goodwani, S., Saternos, H. C., Alasmari, F. F., & Sari, Y. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.024 · Cited by 83 · see citing works
Gass, J. T., Trantham‐Davidson, H., Kassab, A. S., Glen, W. B., Olive, M. F., & Chandler, L. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5616-12.2014 · Cited by 81 · see citing works
Olive, M. F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.01.029 · Cited by 80 · see citing works
Role of the Glutamatergic System in Nicotine Dependence
Liechti, M. E., & Markou, A. (2008) · CNS Drugs · doi:10.2165/00023210-200822090-00001 · Cited by 79 · see citing works
Jin, X., Semenova, S., Yang, L., Ardecky, R., Sheffler, D. J., Dahl, R. S., Conn, P. J., Cosford, N. D. P., & Markou, A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.82 · Cited by 78 · see citing works
Kohara, A., Toya, T., Tamura, S., Watabiki, T., Nagakura, Y., Shitaka, Y., Hayashibe, S., Kawabata, S., & Okada, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087171 · Cited by 78 · see citing works
Drug-Evoked Synaptic Plasticity Causing Addictive Behavior
Lüscher, C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3406-13.2013 · Cited by 75 · see citing works
Heidbreder, C. A., Bianchi, M., Lacroix, L. P., Faedo, S., Perdonà, E., Remelli, R., Cavanni, P., & Crespi, F. (2003) · Synapse · doi:10.1002/syn.10261 · Cited by 74 · see citing works
Bossert, J. M., Poles, G. C., Sheffler-Collins, S. I., & Ghitza, U. E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.008 · Cited by 72 · see citing works
Li, X., Li, J., Gardner, E. L., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06851.x · Cited by 71 · see citing works
Li, X., Li, J., Peng, X., Spiller, K. J., Gardner, E. L., & Xi, Z. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.236 · Cited by 70 · see citing works
Estradiol Facilitation of Cocaine Self-Administration in Female Rats Requires Activation of mGluR5
Martinez, L. A., Gross, K. S., Himmler, B. T., et al. (2016) · eNeuro · doi:10.1523/eneuro.0140-16.2016 · Cited by 67 · see citing works
Ben‐Shahar, O., Sacramento, A. D., Miller, B. W., Webb, S. M., Wroten, M. G., Silva, H. E., Caruana, A. L., Gordon, E. J., Ploense, K. L., Ditzhazy, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3710-12.2013 · Cited by 64 · see citing works
Justinová, Z., Panlilio, L. V., Secci, M. E., Redhi, G. H., Schindler, C. W., Cross, A. J., Mrzljak, L., Medd, A. M., Shaham, Y., & Goldberg, S. R. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.01.014 · Cited by 63 · see citing works
Self-citationSalling, M. C., Faccidomo, S., & Hodge, C. W. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.06.006 · Cited by 62 · see citing works
Xie, X., Lasseter, H. C., Ramirez, D. R., Ponds, K. L., Wells, A. M., & Fuchs, R. A. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00325.x · Cited by 59 · see citing works
Mihov, Y., & Hasler, G. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw002 · Cited by 54 · see citing works
El-Kouhen, O. F., Lehto, S. G., Pan, J. B., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706877 · Cited by 52 · see citing works
Dhanya, R.-P., Sidique, S., Sheffler, D. J., Nickols, H. H., Herath, A., Yang, L., Dahl, R. S., Ardecky, R., Semenova, S., Markou, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1012165 · Cited by 52 · see citing works
Kufahl, P. R., Watterson, L. R., Nemirovsky, N. E., Hood, L. E., Villa, A., Halstengard, C., Zautra, N., & Olive, M. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.037 · Cited by 50 · see citing works
Lost in Translation: CRF1 Receptor Antagonists and Addiction Treatment
Shaham, Y., & de Wit, H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.94 · Cited by 50 · see citing works
Self-citationGregory, K. J., Herman, E. J., Ramsey, A. J., Hammond, A. S., Byun, N. E., Stauffer, S. R., Manka, J. T., Jadhav, S. B., Bridges, T. M., Weaver, C. D., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206623 · Cited by 49 · see citing works
Effects of mGlu1-receptor blockade on ethanol self-administration in inbred alcohol-preferring rats
Besheer, J., Faccidomo, S., Grondin, J. J. M., & Hodge, C. W. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.11.001 · Cited by 46 · see citing works
Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders
Engers, D. W., & Lindsley, C. W. (2013) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2012.10.007 · Cited by 45 · see citing works
Ngomba, R. T., Santolini, I., Biagioni, F., Molinaro, G., Simonyi, Á., van Rijn, C. M., D’Amore, V., Mastroiacovo, F., Olivieri, G., Gradini, R., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.007 · Cited by 44 · see citing works
Recent progress in the discovery and development of negative allosteric modulators of mGluR5.
Lindsley, C. W., & Emmitte, K. A. (2009) · PubMed · Cited by 44 · see citing works
Augier, E., Dulman, R. S., Rauffenbart, C., Augier, G., Cross, A. J., & Heilig, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.107 · Cited by 44 · see citing works
A novel mGluR5 antagonist, MFZ 10‐7, inhibits cocaine‐taking and cocaine‐seeking behavior in rats
Keck, T. M., Zou, M., Bi, G., Zhang, H., Wang, X., Yang, H., Srivastava, R., Gardner, E. L., Xi, Z., & Newman, A. H. (2013) · Addiction Biology · doi:10.1111/adb.12086 · Cited by 39 · see citing works
Achat‐Mendes, C., Platt, D. M., & Spealman, R. D. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196295 · Cited by 39 · see citing works
Crawford, J. T., Roberts, D. C. S., & Beveridge, T. J. R. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.024 · Cited by 39 · see citing works
Watterson, L. R., Kufahl, P. R., Nemirovsky, N. E., Sewalia, K., Hood, L. E., & Olive, M. F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2804-z · Cited by 38 · see citing works
Schmidt, H. D., Kimmey, B. A., Arreola, A. C., & Pierce, R. C. (2015) · Addiction Biology · doi:10.1111/adb.12122 · Cited by 38 · see citing works
Dhanya, R.-P., Sheffler, D. J., Dahl, R. S., Davis, M., Lee, P. S., Yang, L., Nickols, H. H., Cho, H. P., Smith, L. H., D’Souza, M. S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000563 · Cited by 38 · see citing works
Keck, T. M., Yang, H.-J., Bi, G., Huang, Y., Zhang, H., Srivastava, R., Gardner, E. L., Newman, A. H., & Xi, Z. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3106-9 · Cited by 37 · see citing works
Sheardown, M. J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90131-8 · Cited by 34 · see citing works
Group III metabotropic glutamate receptors and drug addiction
Mao, L., Guo, M., Jin, D., Xue, B., & Wang, J. Q. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0291-1 · Cited by 33 · see citing works
Halbout, B., Bernardi, R. E., Hansson, A. C., & Spanagel, R. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1076-13.2014 · Cited by 31 · see citing works
Justinová, Z., Foll, B. L., Redhi, G. H., Markou, A., & Goldberg, S. R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3994-y · Cited by 30 · see citing works
Novel, centrally active mGlu1 antagonists: In vitro and in vivo pharmacology
Lesage, A., Bischoff, F., van Beijsterveldt, L., et al. (2002) · Neuropharmacology · Cited by 30 · see citing works
Sanger, H., Hanna, L., Colvin, E. M., Grubisha, O., Ursu, D., Heinz, B. A., Findlay, J. D., Vivier, R. G., Sher, E., Lodge, D., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.023 · Cited by 29 · see citing works
Li, X., D’Souza, M. S., Ramirez-Niño, A. M., Doherty, J., Cross, A. J., & Markou, A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4220-2 · Cited by 29 · see citing works
Kufahl, P. R., Hood, L. E., Nemirovsky, N. E., Barabas, P., Halstengard, C., Villa, A., Moore, E., Watterson, L. R., & Olive, M. F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00194 · Cited by 28 · see citing works
Sidique, S., Dhanya, R.-P., Sheffler, D. J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3005306 · Cited by 26 · see citing works
The metabotropic glutamate 5 receptor is necessary for extinction of cocaine‐associated cues
Perry, C. J., Reed, F. M., Zbukvic, I., Kim, J. H., & Lawrence, A. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13437 · Cited by 22 · see citing works
Widholm, J. J., Gass, J. T., & Cleva, R. M. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-004 · Cited by 21 · see citing works
Amato, R. J., Felts, A. S., Rodriguez, A. L., Venable, D. F., Morrison, R. D., Byers, F. W., Daniels, J. S., Niswender, C. M., Conn, P. J., Lindsley, C. W., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400070k · Cited by 20 · see citing works
Hellyer, S. D., Leach, K., & Gregory, K. J. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.10.007 · Cited by 19 · see citing works
In Vitro and in Vivo Metabolism of the Antianxiolytic Agent Fenobam in the Rat
Wu, W., McKown, L. A., & O'Neill, P. J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840212 · Cited by 18 · see citing works
Peters, J., Scofield, M. D., Ghee, S. M., Heinsbroek, J. A., & Reichel, C. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.283 · Cited by 17 · see citing works
Acri, J. B., Cross, A. J., & Skolnick, P. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4501-9 · Cited by 17 · see citing works
Keck, T. M., Zou, M., Zhang, P., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3000726 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Improving translation of animal models of addiction and relapse by reverse translation
Venniro, M., Banks, M. L., Heilig, M., Epstein, D. H., & Shaham, Y. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0378-z · Cited by 212 · see citing works
Self-citationMeinhardt, M. W., Pfarr, S., Fouquet, G., Rohleder, C., Meinhardt, M. L., Barroso-Flores, J., Hoffmann, R., Jeanblanc, J., Paul, E., Wagner, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2399 · Cited by 89 · see citing works
Drug addiction: from bench to bedside
Cheron, J., & Kerchove d’Exaerde, A. D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01542-0 · Cited by 75 · see citing works
Yohn, S. E., Galbraith, J., Calipari, E. S., & Conn, P. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00601 · Cited by 36 · see citing works
Jordan, C. J., & Xi, Z.-X. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.811192 · Cited by 20 · see citing works
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05502-y · Cited by 13 · see citing works
- Authors
- Caprioli, D., Justinova, Z., Venniro, M., & Shaham, Y.
- Affiliations
- Sapienza University of Rome (IT)
- National Institutes of Health (US)
- Corresponding author
- Caprioli, Daniele
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 84
- Issue
- 3
- Pages
- 180-192
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC5837933
- OpenAlex
- W2753071628
- Cited by
- 55
- References
- 152
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 10 · 2018: 6
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (ZIADA000434)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- metabotropic glutamate receptors, positive allosteric modulators, negative allosteric modulators, self-administration, relapse, reinstatement of drug seeking, drug craving, addiction treatment, glutamatergic neurotransmission, mGluR2/3 agonist
- MeSH terms
- Allosteric Regulation, Animals, Disease Models, Animal, Humans, Self Administration, Receptors, Metabotropic Glutamate, Excitatory Amino Acid Agents, Substance-Related Disorders, Drug-Seeking Behavior, Craving
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review